STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. More than 3,000,000 ICLs have been sold to date.
180 Million+ Eye TAM
Strong Revenue Growth via Market Share Gains and Creation
Proprietary and Premium family of ICL lenses with R&D Pipeline
99.4% Patient Satisfaction*
Demonstrated Financial Discipline and Strong Balance Sheet
*Patient EVO Visian ICL registry data on file.